ENDOMETRIAL SAMPLER

K990387 · U.A. Medical Products, Inc. · HHK · Apr 20, 1999 · Obstetrics/Gynecology

Device Facts

• Record ID: K990387
• Device Name: ENDOMETRIAL SAMPLER
• Applicant: U.A. Medical Products, Inc.
• Product Code: HHK · Obstetrics/Gynecology
• Decision Date: Apr 20, 1999
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 884.1175
• Device Class: Class 2

Intended Use

Histological biopsy of the uterine mucosal lining or sample extraction of uterine menstrual content.

Device Story

Endometrial Sampler is a manual medical instrument used by clinicians for the collection of uterine tissue or menstrual content. The device is inserted into the uterus to perform a histological biopsy of the mucosal lining or to extract samples. It functions as a diagnostic tool to assist physicians in evaluating uterine health. The output is a physical tissue or fluid sample obtained for laboratory analysis. The device is intended for use in a clinical setting by healthcare professionals. It provides a minimally invasive method for obtaining diagnostic material, facilitating clinical decision-making regarding uterine pathology.

Clinical Evidence

Bench testing only.

Technological Characteristics

Manual endometrial sampling instrument. Design and materials are consistent with standard gynecological biopsy devices. No electronic, software, or energy-based components.

Indications for Use

Indicated for patients requiring histological biopsy of the uterine mucosal lining or sample extraction of uterine menstrual content.

Regulatory Classification

Identification

An endometrial suction curette is a device used to remove material from the uterus and from the mucosal lining of the uterus by scraping and vacuum suction. This device is used to obtain tissue for biopsy or for menstrual extraction. This generic type of device may include catheters, syringes, and tissue filters or traps.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and features the department's name around the perimeter. In the center is a stylized symbol that resembles a bird or a human figure in profile, composed of three curved lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

APR 2 0 1999

Mr. Fanish Engineer President U.A. Medical Products, Inc. 9303-G2 Monroe Road Charlotte, NC 28270

Re: K990387

Endometrial Sampler Dated: February 1, 1999 Received: February 8, 1999 Regulatory Class: II 21 CFR 884.1175/Procode: 85 HHK

Dear Mr. Engineer:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

APT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{1}------------------------------------------------

Section #4

Indications for Use

| 510 (k) Number: | K990387 (to be assigned) |
|-----------------|--------------------------|
|-----------------|--------------------------|

Device Name: Endometrial Sampler

Intended Use: Histological biopsy of the uterine mucosal lining or sample extraction of uterine menstrual content.

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (per CFR 801.109)

OR

Over-the-counter Use

David A. Segura

---

(Division Sign-Off)

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices 19038 510(k) Number

Page 5 of 15